J&J is pursuing premarket approval for the heart shunt. Although advisory committees provide recommendations to the FDA, the ...

The outside advisors analyzed the results of the RELIEVE-HF pivotal trial, which randomized 508 patients to either receive ...

An FDA advisory panel gave a unanimous verdict for an interatrial shunt in heart failure: no way.

Ventura's permanent interatrial shunt was designed to shunt blood from the left to right atrium to improve symptoms in ...

Brian Fahey explains how Adona Medical uses heat to adjust its novel shape memory nitinol implant without harming heart ...

A U.S. FDA advisory panel voted unanimously against approving Johnson & Johnson’s V-Wave Ventura shunt for heart failure patients not helped by medications. The circulatory panel voted emphatically 15 ...

Background and aims: The shape of dilution curve will dramatically change after indicator passes through the cardiopulmonary system in the presence of intra-cardiac shunts and a PDA. The purpose of ...

Patients with heart failure who had a small shunt inserted between the heart's left and right atria did not see any significant benefits overall compared with those who received a placebo procedure ...

Patients who responded positively to shunt treatment experienced more beneficial changes in their heart's structure and function compared with nonresponders. After 2 years of follow-up, a post hoc ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

For babies born with a certain heart defect, implantation of a "shunt" is essential to their survival. A new type of shunt can be expanded using light after it's been implanted, potentially ...